Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 12.81
+0.13 (1.03%)
At close: Feb 27, 2026
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 5.02 billion as of February 27, 2026. Its market cap has increased by 30.05% in one year.
Market Cap
5.02B
Enterprise Value
4.31B
Revenue
670.43M
Ranking
n/a
PE Ratio
40.59
Stock Price
12.81
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has decreased from 5.31B to 5.02B, a decrease of -5.37%. That is a compound annual growth rate of -1.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 5.02B | 8.65% |
| Dec 31, 2025 | 4.62B | 19.35% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
| Nov 16, 2022 | 5.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Yatai Pharmaceutical | 5.26B |
| Shandong Sinobioway Biomedicine | 5.23B |
| Zhuhai Rundu Pharmaceutical | 5.19B |
| Jianmin Pharmaceutical Group | 5.10B |
| Bide Pharmatech | 5.06B |
| Tibet Duo Rui Pharmaceutical | 5.06B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.99B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.92B |